Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2024-10-08 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 益丰大药房连锁股份有限公司 regarding the completion of industrial and commercial registration changes, including changes in registered capital, business scope, and amendments to the company charter. It includes details such as the new business license information, company type, address, legal representative, registered capital, and detailed business scope. The document is relatively short (1574 characters) and does not contain financial statements, audit information, or detailed financial data. It is not a report like an Annual Report (10-K) or Interim Report (IR), nor is it a certification or voting result. It is a formal announcement about company registration changes, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2024-10-08 Chinese
益丰药房关于归还暂时用于补充流动资金的可转换公司债券募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Yifeng Pharmacy Chain Co., Ltd. regarding the repayment of temporarily used raised funds for working capital. It references previous announcements about the use of idle raised funds and details the amounts repaid and remaining. The content focuses on capital usage and repayment related to convertible bonds and fundraising activities. There are no financial statements or comprehensive financial data presented, nor is it a report or transcript. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length is short and it is not merely announcing the publication of a report, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2024-09-30 Chinese
益丰药房关于参加2024年湖南辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by the company about its participation in an investor online collective reception day event organized by regulatory and industry bodies. It mentions the date and time of the event and that company executives will discuss the 2023 annual and 2024 half-year performance, governance, strategy, and other topics. The document is short (631 characters) and serves as a notice of an upcoming investor interaction event rather than a detailed report or transcript. It does not contain financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor relations activities and does not fit other specific categories like Investor Presentation or Interim Report, which would require more substantive content.
2024-09-27 Chinese
益丰药房关于控股股东及其一致行动人减持可转换公司债券的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the reduction (sale) of convertible bonds held by the controlling shareholder and its concerted parties. It details the number of bonds held before and after the sale, the dates of the sale, and the percentage of total issuance affected. There is no financial report, earnings data, or management discussion. The document is a formal disclosure of a transaction involving the company's own securities (convertible bonds). This fits the category of Transaction in Own Shares (POS), which includes share repurchases or sales of company securities by insiders or controlling shareholders.
2024-09-27 Chinese
益丰药房关于实施2024年半年度权益分派时“益丰转债”停止转股的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1255 characters) from Yifeng Pharmacy Chain Co., Ltd. regarding the suspension of convertible bond conversion due to the implementation of the 2024 semi-annual dividend distribution. It includes details about the suspension period, dividend amount, and references to previous announcements about the dividend plan. There are no financial statements or detailed financial analysis present. The document serves as a notification about the operational impact on convertible bonds during the dividend distribution period rather than a full financial report or earnings release. It fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about securities trading and corporate actions without substantive financial data or report content.
2024-09-25 Chinese
益丰药房2024年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 third extraordinary general meeting of shareholders of Yifeng Pharmacy Chain Co., Ltd. It includes information about the meeting date, location, attendance, voting results on various proposals, and legal witness statements. The content focuses on the official voting results and procedural compliance of the shareholders' meeting. It does not contain financial statements, management discussion, or detailed report content. The document length is 2157 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-09-23 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.